Published in J Immunol Methods on October 19, 1990
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. Proc Natl Acad Sci U S A (1992) 0.97
C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes. Immunology (1991) 0.77
Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun (1999) 1.87
Optical performance of multifocal intraocular lenses. J Cataract Refract Surg (1990) 1.74
Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med (1990) 1.68
PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist (1997) 1.67
Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Methods (1983) 1.53
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun (1994) 1.38
Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol (2001) 1.23
A semi-electronic device for measuring delayed hypersensitivity in the mouse by footpad swelling. J Immunol Methods (1976) 1.16
Identification of RFLP markers closely linked to the bolting gene B and their significance for the study of the annual habit in beets (Beta vulgaris L.). Theor Appl Genet (1994) 1.14
In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J Immunol Methods (1991) 1.09
Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents (2001) 1.06
Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of gram-positive origin? J Bacteriol (1999) 1.06
Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes. J Immunol Methods (1980) 0.99
The linkage disequilibrium between chloroplast DNA and mitochondrial DNA haplotypes in Beta vulgaris ssp. maritima (L.): the usefulness of both genomes for population genetic studies. Mol Ecol (2000) 0.98
Association of familial deficiency of mannose-binding lectin and meningococcal disease. Lancet (1999) 0.97
Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. Proc Natl Acad Sci U S A (1992) 0.97
The origin and evolution of weed beets: consequences for the breeding and release of herbicide-resistant transgenic sugar beets. Theor Appl Genet (1993) 0.96
Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med (Berl) (2012) 0.95
Rapid isolation and characterization of native mouse complement components C3 and C5. J Immunol Methods (1989) 0.95
Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline. Clin Exp Immunol (1979) 0.94
Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method. Clin Diagn Lab Immunol (1995) 0.92
Encephalomyelitis-associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology (2000) 0.92
Cellular and humoral adjuvant activity of mistletoe extract. Immunobiology (1979) 0.92
Hamilton's rule, imprinting and parent-offspring conflict over seed mass in partially selfing plants. J Evol Biol (2005) 0.89
The selective localization of B lymphocytes in the spleen and the role of complement receptors. Eur J Immunol (1985) 0.89
Acute exercise and skeletal muscle antioxidant and metabolic enzymes: effects of fiber type and age. Am J Physiol (1993) 0.88
A one-step isolation procedure for phospholipase A2-free cobra venom factor by fast protein liquid chromatography. J Immunol Methods (1987) 0.86
Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar. J Infect Dis (1996) 0.85
Stimulation of the immune response against SRBC by reduction of corticosterone plasma levels: mediation by mononuclear phagocytes. Cell Immunol (1976) 0.85
How flavonoids inhibit the generation of luminol-dependent chemiluminescence by activated human neutrophils. Chem Biol Interact (1990) 0.85
Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes. Infect Immun (1996) 0.84
Metabolic and antioxidant enzyme activities in the diaphragm: effects of acute exercise. Respir Physiol (1994) 0.82
Pneumococcal immune adherence to human erythrocytes. Eur J Clin Invest (2003) 0.81
Activity-guided isolation and identification of Azadirachta indica bark extract constituents which specifically inhibit chemiluminescence production by activated human polymorphonuclear leukocytes. Planta Med (1991) 0.81
Effects of immunological adjuvants on the mouse complement system. I. The inability of the polyanion heparin to act as an adjuvant is paralleled by inefficient alternative complement pathway inhibition. Int J Immunopharmacol (1983) 0.81
Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy. Scand J Rheumatol Suppl (1990) 0.81
C5 does not play a major role in the immune response of mice to SRBC in vivo. Scand J Immunol (1991) 0.80
Cyclophosphamide-like cellular immunostimulation induced by 6-thioguanine (Lanvis). Immunology (1978) 0.80
Sex-limited protein: in vitro and in vivo functions. Clin Exp Immunol (1999) 0.80
Moraxella catarrhalis in acute laryngitis: infection or colonization? J Infect Dis (1996) 0.80
C1-inhibitor prevents PEG fractionation-induced, EDTA-resistant activation of mouse complement. Mol Immunol (1992) 0.79
Simple sugars with affinity for the macrophage asialoglycoprotein receptor are adjuvants for the humoral immune response to neuraminidase-treated sheep erythrocytes. J Immunol (1986) 0.79
Quantification of in vitro antibody secretion by immune spleen cells. J Immunol Methods (1977) 0.78
Differential potencies of corticosterone and hydrocortisone in immune and immune-related processes in the mouse. Int J Immunopharmacol (1979) 0.78
Study of the optimal reaction conditions for assay of the mouse alternative complement pathway. J Immunol Methods (1985) 0.78
Analytic study of the differential anticomplementary effects of dextran sulphate and heparin in the assay for the mouse alternative pathway. Int Arch Allergy Appl Immunol (1985) 0.78
Reaction products of 1-naphthol with reactive oxygen species prevent NADPH oxidase activation in activated human neutrophils, but leave phagocytosis intact. Free Radic Biol Med (1990) 0.78
A study of the sensitivity of erythrocytes to lysis by heterologous sera via the alternative complement pathway. Vet Immunol Immunopathol (1983) 0.78
Consumer evaluations of food risk management quality in Europe. Risk Anal (2007) 0.78
Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases. Clin Exp Immunol (1984) 0.77
C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes. Immunology (1991) 0.77
Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients. Br J Rheumatol (1988) 0.76
Plant-derived metabolites with synergistic antioxidant activity. Immunol Today (1995) 0.75
Conflicts, security and marginalisation: institutional change of the pastoral commons in a 'glocal' world. Rev Sci Tech (2016) 0.75
Effects of immunological adjuvants on the mouse complement system--II. Anti-complementary effects of surface-active compounds. Int J Immunopharmacol (1986) 0.75
Rapid, activity-guided isolation of sex-limited protein (Slp) from mouse serum by fractionated precipitation and high-performance liquid chromatography. J Immunol Methods (1994) 0.75
Antigen-specific helper activity in serum of mice primed with sheep red cells II. Partial purification of the factors involved. Int J Immunopharmacol (1983) 0.75
House dust allergen activates the classical complement pathway in mouse serum. Immunol Lett (1986) 0.75
House dust extracts contain potent immunological adjuvants. Immunol Lett (1987) 0.75